Cargando…
Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study
Autores principales: | Sriphoosanaphan, Supachaya, Suksawatamnuay, Sirinporn, Srisoonthorn, Nunthiya, Siripon, Nipaporn, Thaimai, Panarat, Makhasen, Wanwisar, Mungnamtrakul, Nawakodchamon, Thanapirom, Kessarin, Nonthasoot, Bunthoon, Hansasuta, Pokrath, Komolmit, Piyawat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252404/ http://dx.doi.org/10.1016/S0168-8278(22)01860-8 |
Ejemplares similares
-
Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022) -
Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022) -
Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022) -
Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study
por: Thanapirom, Kessarin, et al.
Publicado: (2022) -
Psychometric Hepatic Encephalopathy Score for the Diagnosis of Minimal Hepatic Encephalopathy in Thai Cirrhotic Patients
por: Thanapirom, Kessarin, et al.
Publicado: (2023)